BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11996788)

  • 1. Cytogenetic and molecular analysis of early stage renal cell carcinomas in a family with a translocation (2;3)(q35;q21).
    Bodmer D; Eleveld M; Ligtenberg M; Weterman M; van der Meijden A; Koolen M; Hulsbergen-van der Kaa C; Smits A; Smeets D; Geurts van Kessel A
    Cancer Genet Cytogenet; 2002 Apr; 134(1):6-12. PubMed ID: 11996788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
    Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.
    Kanayama H; Lui WO; Takahashi M; Naroda T; Kedra D; Wong FK; Kuroki Y; Nakahori Y; Larsson C; Kagawa S; Teh BT
    J Med Genet; 2001 Mar; 38(3):165-70. PubMed ID: 11238683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of a novel MFS transporter gene, DIRC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21).
    Bodmer D; Eleveld M; Kater-Baats E; Janssen I; Janssen B; Weterman M; Schoenmakers E; Nickerson M; Linehan M; Zbar B; van Kessel AG
    Hum Mol Genet; 2002 Mar; 11(6):641-9. PubMed ID: 11912179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation.
    Bodmer D; Eleveld MJ; Ligtenberg MJ; Weterman MA; Janssen BA; Smeets DF; de Wit PE; van den Berg A; van den Berg E; Koolen MI; Geurts van Kessel A
    Am J Hum Genet; 1998 Jun; 62(6):1475-83. PubMed ID: 9585616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
    Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
    Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters.
    Kondo K; Yao M; Yoshida M; Kishida T; Shuin T; Miura T; Moriyama M; Kobayashi K; Sakai N; Kaneko S; Kawakami S; Baba M; Nakaigawa N; Nagashima Y; Nakatani Y; Hosaka M
    Genes Chromosomes Cancer; 2002 May; 34(1):58-68. PubMed ID: 11921283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation.
    Schmidt L; Li F; Brown RS; Berg S; Chen F; Wei MH; Tory K; Lerman I; Zbar B
    Cancer J Sci Am; 1995; 1(3):191-5. PubMed ID: 9166475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of biallelic inactivation of the von Hippel-Lindau tumor suppressor gene VHL in patients of renal cell carcinoma patient].
    Liu N; Gong K; Zhang N; Guo HF; Na X; Wu G; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):115-7. PubMed ID: 15771820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma.
    Hamano K; Esumi M; Igarashi H; Chino K; Mochida J; ISHIDA And H; Okada K
    J Urol; 2002 Feb; 167(2 Pt 1):713-7. PubMed ID: 11792959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development.
    van den Berg A; Dijkhuizen T; Draaijers TG; Hulsbeek MM; Maher ER; van den Berg E; Störkel S; Buys CH
    Genes Chromosomes Cancer; 1997 Aug; 19(4):228-32. PubMed ID: 9258657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of endothelial cells derived from von Hippel-Lindau-related renal cancer.
    Los M; Kerckhaert OA; Zewald R; van Amstel HK; Voest EE
    J Natl Cancer Inst; 2000 Oct; 92(20):1688-9. PubMed ID: 11036115
    [No Abstract]   [Full Text] [Related]  

  • 16. Chromosome 3 translocations and the risk to develop renal cell cancer: a Dutch intergroup study.
    Van Erp F; Van Ravenswaaij C; Bodmer D; Eleveld M; Hoogerbrugge N; Mulders P; Geurts van Kessel A
    Genet Couns; 2003; 14(2):149-54. PubMed ID: 12872808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization.
    Sprenger SH; Gijtenbeek JM; Wesseling P; Sciot R; van Calenbergh F; Lammens M; Jeuken JW
    J Neurooncol; 2001 May; 52(3):241-7. PubMed ID: 11519854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.
    Sükösd F; Kuroda N; Beothe T; Kaur AP; Kovacs G
    Cancer Res; 2003 Jan; 63(2):455-7. PubMed ID: 12543802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.